Founded as an early-stage, Series A funded company, Portal Instruments is dedicated to revolutionizing the medical device industry with its core mission of transforming patient experiences through innovative technology. The company's vision is to eliminate the pain, anxiety, and handling difficulties associated with traditional needle-based injections. Portal Instruments is developing a needle-free drug delivery platform designed for the effortless administration of high-viscosity biologics, aiming to improve patient compliance and overall healthcare outcomes.

Notable figures affiliated with Portal Instruments include experienced professionals from the medical device and biotechnology sectors. The company has attracted significant interest from investors focused on disruptive healthcare technologies. Key achievements include the successful development of their needle-free technology platform, which represents a groundbreaking advancement in biologics delivery. Although still in development and not yet available for sale, Portal Instruments' innovative approach has the potential to significantly impact patient care and set new standards in drug delivery systems.